Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
19.06
-0.02 (-0.10%)
At close: Jul 15, 2026, 4:00 PM EDT
19.22
+0.16 (0.84%)
After-hours: Jul 15, 2026, 6:25 PM EDT
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of $2.1 billion as of July 15, 2026. Its market cap has increased by 80.02% in one year.
Market Cap
2.10B
Enterprise Value
1.40B
1-Year Change
80.02%
Ranking
Category
Stock Price
$19.06
Market Cap Chart
Since June 18, 2014, Viridian Therapeutics's market cap has increased from $34.70M to $2.10B, an increase of 5,965.57%. That is a compound annual growth rate of 40.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 1.97B | -33.79% |
| Dec 31, 2025 | 2.97B | 95.60% |
| Dec 31, 2024 | 1.52B | 32.59% |
| Dec 29, 2023 | 1.15B | -2.59% |
| Dec 30, 2022 | 1.18B | 173.74% |
| Dec 31, 2021 | 429.50M | 567.96% |
| Dec 31, 2020 | 64.30M | 320.26% |
| Dec 31, 2019 | 15.30M | -83.62% |
| Dec 31, 2018 | 93.40M | -59.86% |
| Dec 29, 2017 | 232.70M | 6,363.89% |
| Dec 30, 2016 | 3.60M | -55.00% |
| Dec 31, 2015 | 8.00M | -16.67% |
| Dec 31, 2014 | 9.60M | -72.33% |
| Jun 18, 2014 | 34.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocular Therapeutix | 2.16B |
| Mesoblast | 2.11B |
| Kardigan | 2.10B |
| Palvella Therapeutics | 2.09B |
| ADMA Biologics | 2.08B |
| AnaptysBio | 2.07B |
| Aurinia Pharmaceuticals | 2.06B |
| Harmony Biosciences Holdings | 2.06B |